BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7085073)

  • 21. Chemotaxis of radiolabeled equine neutrophils.
    Camp CJ; Leid RW
    Am J Vet Res; 1982 Mar; 43(3):397-401. PubMed ID: 7073055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of human complement component 1 inactivator on neutrophil chemotaxis and chemotactic deactivation.
    Patrick RA; Hollers JC; Liu DY; Giese BH; Smith CW
    Infect Immun; 1980 Jun; 28(3):700-7. PubMed ID: 7399690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro.
    Vicioso MA; Garaud JJ; Réglier-Poupet H; Lebeaut A; Gougerot-Pocidalo MA; Chollet-Martin S
    Eur Cytokine Netw; 1998 Sep; 9(3):247-53. PubMed ID: 9831173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in superoxide production by nonmigrating and migrating human monocyte subpopulations.
    Harvath L; Lazdins JK; Alteri E; Leonard EJ
    Biochem Biophys Res Commun; 1982 Sep; 108(1):392-8. PubMed ID: 6293488
    [No Abstract]   [Full Text] [Related]  

  • 25. Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms.
    McPhail LC; Snyderman R
    J Clin Invest; 1983 Jul; 72(1):192-200. PubMed ID: 6409928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement activation products and monocyte migratory function in trauma.
    Antrum RM; Solomkin JS
    Curr Surg; 1985; 42(4):301-3. PubMed ID: 3875452
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotactically responsive and nonresposive forms of a continuous human monocyte cell line.
    Fischer DG; Pike MC; Koren HS; Snyderman R
    J Immunol; 1980 Jul; 125(1):463-5. PubMed ID: 7381208
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of CD 14 on migrated monocytes by specific antibody: a possible quantification for blood monocyte chemotaxis.
    Tekstra J; Tuk CW; Beelen RH
    Immunobiology; 1996 Oct; 195(4-5):491-8. PubMed ID: 8933153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of specific receptors for N-formylated chemotactic peptides in a human monocyte cell line stimulated with lymphokines.
    Pike MC; Fischer DG; Koren HS; Snyderman R
    J Exp Med; 1980 Jul; 152(1):31-40. PubMed ID: 7400755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocyte dysfunction in severe trauma: evidence for the role of C5a in deactivation.
    Antrum RM; Solomkin JS
    Surgery; 1986 Jul; 100(1):29-37. PubMed ID: 3726758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of monocyte migration by recombinant macrophage colony-stimulating factor.
    Wang JM; Griffin JD; Rambaldi A; Chen ZG; Mantovani A
    J Immunol; 1988 Jul; 141(2):575-9. PubMed ID: 3290341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of filter-bound IgA in inhibiting polymorphonuclear leukocyte chemotaxis.
    Schröder JM; Christophers E
    Immunobiology; 1983 Mar; 164(2):127-35. PubMed ID: 6852861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beryllium-stimulated in vitro migration of peripheral blood lymphocytes.
    Sawyer RT; Doherty DE; Schumacher BA; Newman LS
    Toxicology; 1999 Nov; 138(3):155-63. PubMed ID: 10593506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal lymphocyte chemotactic factor specifically attracts OKT4-positive lymphocytes.
    Zachariae C; Ternowitz T; Larsen CG; Nielsen V; Thestrup-Pedersen K
    Arch Dermatol Res; 1988; 280(6):354-7. PubMed ID: 2903723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant reduction of human monocyte chemotactic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma.
    Müller R; Zheng M; Mrowietz U
    Exp Dermatol; 1997 Apr; 6(2):81-6. PubMed ID: 9209889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocytes recruited to sites of inflammation express a distinctive proinflammatory (P) phenotype.
    Owen CA; Campbell MA; Boukedes SS; Campbell EJ
    Am J Physiol; 1994 Dec; 267(6 Pt 1):L786-96. PubMed ID: 7810683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro studies of human monocyte migration across endothelium in response to leukotriene B4 and f-Met-Leu-Phe.
    Migliorisi G; Folkes E; Pawlowski N; Cramer EB
    Am J Pathol; 1987 Apr; 127(1):157-67. PubMed ID: 3031985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation.
    O'Flaherty JT; Hammett MJ; Shewmake TB; Wykle RL; Love SH; McCall CE; Thomas MJ
    Biochem Biophys Res Commun; 1981 Nov; 103(2):552-8. PubMed ID: 6277309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.